Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease

Aliment Pharmacol Ther 2011; 34: 533–543

[1]  Toshio Ohhashi,et al.  PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. , 2004, Cancer cell.

[2]  R. Gausas,et al.  Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. , 2004, International journal of molecular medicine.

[3]  P. Bruneval,et al.  Giant cell arteritis localized to the colon associated with Crohn's disease , 2001, Histopathology.

[4]  K. Alitalo,et al.  The lymphatic vasculature: recent progress and paradigms. , 2005, Annual review of cell and developmental biology.

[5]  Tatiana V. Petrova,et al.  Lymphangiogenesis in development and human disease , 2005, Nature.

[6]  K. Alitalo,et al.  Vascular growth factors and lymphangiogenesis. , 2002, Physiological reviews.

[7]  J. Colombel,et al.  Lymphatics, tertiary lymphoid organs and the granulomas of Crohn’s disease: an immunohistochemical study , 2011, Alimentary pharmacology & therapeutics.

[8]  E. Schwarz,et al.  Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. , 2009, Arthritis and rheumatism.

[9]  F. Aloisi,et al.  Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.

[10]  Adrian L Harris,et al.  Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. , 2002, Cancer research.

[11]  Yihai Cao,et al.  Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Ishiwata,et al.  Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. , 2002, The Journal of rheumatology.

[13]  M. Detmar,et al.  Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. , 2005, The American journal of pathology.

[14]  C. Ligorio,et al.  Lymphangiogenesis in Crohn’s disease: an immunohistochemical study using monoclonal antibody D2-40 , 2007, Virchows Archiv.

[15]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[16]  A. Neugut,et al.  Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. , 1999, Urology.

[17]  K. Alitalo,et al.  Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C* , 1998, The Journal of Biological Chemistry.

[18]  G. Schaffner,et al.  Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. , 1997, American Journal of Pathology.

[19]  R. Pounder,et al.  Is proximal demarcation of ulcerative colitis determined by the territory of the inferior meseriteric artery? , 1995, The Lancet.

[20]  A. Hansen,et al.  Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. , 2006, Blood.

[21]  E. Kaiserling,et al.  Lymphatic vessels in the colonic mucosa in ulcerative colitis. , 2003, Lymphology.

[22]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[23]  Y. Maehara,et al.  Microvessel quantification and its possible relation with liver metastasis in colorectal cancer , 1996, Cancer.

[24]  Guillermo Oliver,et al.  Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity , 2005, Nature Genetics.

[25]  K. Alitalo,et al.  Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. , 2002, The Journal of rheumatology.

[26]  E. Mooney,et al.  Relation of granulomas to lymphatic vessels in Crohn's disease. , 1995, Journal of clinical pathology.

[27]  D. Zawieja,et al.  Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. , 2010, Blood.

[28]  D. Jackson,et al.  Inflammation-induced Uptake and Degradation of the Lymphatic Endothelial Hyaluronan Receptor LYVE-1*♦ , 2007, Journal of Biological Chemistry.

[29]  O. Thaunat,et al.  Is defective lymphatic drainage a trigger for lymphoid neogenesis? , 2006, Trends in immunology.

[30]  P. Tak,et al.  Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints , 2008, Annals of the rheumatic diseases.

[31]  H. Sakurai,et al.  Tumour-derived fibroblast growth factor-2 exerts lymphangiogenic effects through Akt/mTOR/p70S6kinase pathway in rat lymphatic endothelial cells. , 2007, European journal of cancer.

[32]  M. Héroult,et al.  Inflammatory triggers of lymphangiogenesis. , 2003, Lymphatic research and biology.

[33]  S. Schoppmann,et al.  Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease , 2003, Virchows Archiv.

[34]  P. Rutgeerts,et al.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.

[35]  D. Jackson.  Biology of the lymphatic marker LYVE‐1 and applications in research into lymphatic trafficking and lymphangiogenesis , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[36]  J. Colombel,et al.  The forgotten role of lymphangitis in Crohn’s disease , 2007, Gut.

[37]  K. Ahn,et al.  Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes. , 2007, The Journal of rheumatology.